Persistent activation of NF-κB contributes to endothelial dysfunction, chemokines-driven neutrophil recruitment, and an increased likelihood of thrombus recurrence, worsening the prognosis of thrombotic diseases (47–49). Here, NFKB1 is linked to endothelial dysfunction.